Home » Topics » Regulatory » Patents

Patents
RSS

Prenyl-protein transferase inhibitors reported by Merck & Co.

Jan. 3, 1997

Antidementia agents reported by Eisai

Jan. 2, 1997

T Cell Sciences describes anti-CETP vaccines

Jan. 2, 1997

Anti-gp130 MAbs for inflammatory disorders and myeloma

Jan. 2, 1997

Novel human serine protease inhibitor for pancreatitis claimed by Incyte

Jan. 2, 1997

Mitotix reports antiviral/anticancer antisense constructs

Jan. 2, 1997

Nissan Chemical discloses novel cardiovascular agents

Jan. 2, 1997

Novel antiangiogenic compounds from ADIR

Jan. 2, 1997

Natural antitumor/antifungal agent disclosed by Fujisawa

Dec. 31, 1996

Dolastatin 10 derivatives from Teikoku Hormone

Dec. 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.